Investing in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians
Canada's COVID-19 Immunity Task Force (CITF) announces its support for a new SARS-CoV-2 seroprevalence study focused on aging Canadians, a population that has been shown to be at greatest risk for severe outcomes from COVID-19 disease. This $4 million investment will be carried out by the Canadian Longitudinal Study on Aging (CLSA), a national platform for research [...]